Selected article for: "International license and SARS sequence"

Author: Jrhau Lung; Yu-Shih Lin; Yao-Hsu Yang; Yu-Lun Chou; Geng-He Chang; Ming-Shao Tsai; Cheng-Ming Hsu; Reming-Albert Yeh; Li-Hsin Shu; Yu-Ching Cheng; Hung Te Liu; Ching-Yuan Wu
Title: The potential SARS-CoV-2 entry inhibitor
  • Document date: 2020_3_26
  • ID: 7w79zeib_5
    Snippet: In addition, Phe486 of RBD forms van der Waals forces with Met82 of . CC-BY 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.26.009803 doi: bioRxiv preprint 6 ACE24 (Fig 1) (5) . However, the sequence identity of the spike protein between SARS-CoV-2 and SARS-CoV is 76%, and major variation exists at the N-terminus enc.....
    Document: In addition, Phe486 of RBD forms van der Waals forces with Met82 of . CC-BY 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.26.009803 doi: bioRxiv preprint 6 ACE24 (Fig 1) (5) . However, the sequence identity of the spike protein between SARS-CoV-2 and SARS-CoV is 76%, and major variation exists at the N-terminus encoding the RBD(7). Since RBD of spike protein is surface-exposed and promotes entry into host cells, it could be a potential target for therapy and vaccination using small molecules and neutralizing antibodies to treat COVID-19 (4, 8) .

    Search related documents:
    Co phrase search for related documents